A Proactive Approach for Managing COVID-19: The Importance of Understanding the Motivational Roots of Vaccination Hesitancy for SARS-CoV2

Steven Taylor, Caeleigh A Landry, Michelle M Paluszek, Rosalind Groenewoud, Geoffrey S Rachor, Gordon J G Asmundson, Steven Taylor, Caeleigh A Landry, Michelle M Paluszek, Rosalind Groenewoud, Geoffrey S Rachor, Gordon J G Asmundson

Abstract

Importance: Vaccination hesitancy-the reluctance or refusal to be vaccinated-is a leading global health threat (World Health Organization, 2019). It is imperative to identify the prevalence of vaccination hesitancy for SARS-CoV2 in order to understand the scope of the problem and to identify its motivational roots in order to proactively prepare to address the problem when a vaccine eventually becomes available.

Objective: To identify (1) the prevalence of vaccination hesitancy for a SARS-CoV2 vaccine, (2) the motivational roots of this hesitancy, and (3) the most promising incentives for improving the likelihood of vaccination uptake when a vaccine does become available.

Design setting and participants: A cross-sectional sample of 3,674 American and Canadian adults assessed during the COVID-19 pandemic in May 2020.

Main outcomes: Measures of vaccination intention (i.e., "If a vaccine for COVID-19 was available, would you get vaccinated?"), attitudes toward vaccines in general and specific to SARS-CoV2 using the Vaccination Attitudes Examination Scale, and incentives for getting vaccinated for those who reported they would not get vaccinated.

Results: Many American (25%) and Canadian (20%) respondents said that they would not get vaccinated against SARS-CoV2 if a vaccine was available. Non-adherence rates of this magnitude would make it difficult or impossible to achieve herd immunity. Vaccine rejection was most strongly correlated with mistrust of vaccine benefit, and also correlated with worry about unforeseen future effects, concerns about commercial profiteering from pharmaceutical companies, and preferences for natural immunity. When asked about incentives for getting vaccinated, respondents were most likely to report that evidence for rigorous testing and safety of the vaccine were of greatest importance.

Conclusions and relevance: Vaccination hesitancy is a major looming problem for COVID-19. To improve vaccine uptake, it is imperative that the vaccine is demonstrated to the public to be rigorously tested and not perceived as rushed or premature in its dissemination.

Keywords: COVID-19; SARSCoV2; coronavirus; pandemic; vaccination; vaccination attitudes; vaccination hesitancy.

Copyright © 2020 Taylor, Landry, Paluszek, Groenewoud, Rachor and Asmundson.

References

    1. Angus Reid Institute (2020). COVID-19: Three-in-five worry about side-effects of a vaccine; many plan to take a “wait and see” approach, 2020, August 4. Available at: (accessed August 21, 2020).
    1. Bangerter A., Krings F., Mouton A., Gilles I., Green E. G. T., Clémence A. (2012). Longitudinal investigation of public trust in institutions relative to the 2009 H1N1 pandemic in Switzerland. PLoS One 7:e49806. 10.1371/journal.pone.0049806
    1. Barello S., Nania T., Dellafiore F., Graffigna G., Caruso R. (2020). “Vaccine hesitancy” among university students in Italy during the COVID-19 pandemic. Eur. J. Epidemiol. 35 781–783. 10.1007/s10654-020-00670-z
    1. Bracken M. (2020). A trend that worries health experts: As U.S. gets closer to COVID-19 vaccine, fewer people say they’d get one. Available at: (accessed September 19, 2020).
    1. Cohen J. (1988). Statistical Power Analyses for the Behavioral Sciences, 2nd ed, 1988. Mahwaj, NJ: Erlbaum.
    1. Dodd R. H., Cvejic E., Bonner C., Pickles K., McCaffery K. J. (2020). Willingness to vaccinate against COVID-19 in Australia. Lancet Infect. Dis. [Epub ahead of print] 10.1016/S1473-3099(20)30559-4
    1. Fine P., Eames K., Heymann D. L. (2011). “Herd immunity”: a rough guide. Clin. Infect. Dis. 52 911–916. 10.1093/cid/cir007
    1. Fisher K. A., Bloomstone S. J., Walder J., Crawford S., Fouayzi H., Mazor K. M. (2020). Attitudes toward a potential SARS-CoV-2 vaccine: a survey of U.S. adults. Ann. Intern. Med. [Epub ahead of print]. 10.7326/M20-3569
    1. Gallup P. (2020). One in three Americans would not get COVID-19 vaccine, 2020, August 2. Available at: (accessed August 21, 2020).
    1. Group C. O. C. O. N. E. L. (2020). A future vaccination campaign against COVID-19 at risk of vaccine hesitancy and politicisation. Lancet Infect. Dis. 20 769–770. 10.1016/S1473-3099(20)30426-6
    1. Hornsey M. J., Harris E. A., Fielding K. S. (2018). The psychological roots of anti-vaccination attitudes: a 24-nation investigation. Health Psychol. 37 307–315. 10.1037/hea0000586
    1. Liu Y., Gayle A. A., Wilder-Smith A., Rocklov J. (2020). The reproductive number of COVID-19 is higher compared to SARS coronavirus. J. Travel Med. 27 1–4. 10.1093/jtm/taaa021
    1. Maltezou H. C., Theodoridou K., Ledda C., Rapisarda V., Theodoridou M. (2018). Vaccination of healthcare workers: is mandatory vaccination needed? Expert Rev. Vaccines 18 5–13. 10.1080/14760584.2019.1552141
    1. Martin L. R., Petrie K. J. (2017). Understanding the dimensions of anti-vaccination attitudes: the vaccination attitudes examination (VAX) scale. Ann. Behav. Med. 2017 652–660. 10.1007/s12160-017-9888-y
    1. McKie R. (2020). COVID-19: Only Half of Britons Would Definitely Have Vaccination. Available at: (accessed September 19, 2020).
    1. Neumann-Böhme S., Varghese N. E., Sabat I., Barros P. P., Brouwer W., van Exel J., et al. (2020). Once we have it, will we use it? A European survey on willingness to be vaccinated against COVID-19. Eur. J. Health Econ. 21 977–982. 10.1007/s10198-020-01208-6
    1. Palamenghi L., Barello S., Boccia S., Graffigna G. (2020). Mistrust in biomedical research and vaccine hesitancy: the forefront challenge in the battle against COVID-19 in Italy. Eur. J. Epidemiol. 35 785–788. 10.1007/s10654-020-00675-8
    1. Statistics Canada (2020). Census Profile, 2016 Census. Available at: (accessed August 23, 2020).
    1. Taylor S. (2019). The Psychology of Pandemics: Preparing for the Next Global Outbreak of Infectious Disease. Newcastle upon Tyne, UK: Cambridge Scholars Publishing.
    1. U.S. Food & Drug Administration (2020). FDA Cautions Against Use of Hydroxychloroquine or Chloroquine for COVID-19 Outside of the Hospital Setting or a Clinical Trial Due to Risk of Heart Rhythm probleMs. Available at: (accessed August 23, 2020).
    1. United States Census Bureau (2020). Age and Sex Composition in the United States: 2019. Available at: (accessed August 23, 2020).
    1. World Health Organization (2019). Ten Threats to Global Health in 2019. Available at: (accessed February 25, 2019).
    1. World Health Organization (2020). The Guide to Tailoring Immunization Programs: Increasing coverage of infant and child vaccination in the WHO European Region. Available at: (accessed June 3, 2020).
    1. Yaqub O., Castle-Clarke S., Sevdalis N., Chataway J. (2014). Attitudes to vaccination: a critical review. Soc. Sci. Med. 112 1–11. 10.1016/j.socscimed.2014.04.018

Source: PubMed

Sponzoři a spolupracovníci

Zdravotní podmínky

Drogové intervence

3
Předplatit